References
- Zee DS. Perspectives on the pharmacotherapy of vertigo. Arch Otolaryngot 1985; 111: 609–12
- Dieringer N, Precht W. Modification of synaptic input following unilateral labyrinthectomy. Nature 1977; 269: 431–3
- Wamsley J K, Lewis M S, Young W S, Kuhar MJ. Auloradiographic localization of cholinergic receptors in rat brainstem. J Neurosci 1981; 1: 176–91
- Palacios J M, Wamsley J K, Kuhar MJ. The distribution of histamine H l receptors in the rat brain: An autoradiographic study. Neuroscience 1981; 6: 15–37
- Kirsten E B, Schoener E P, Wang SC. Effects of d-amphetamine on single vestibular neurons. J Pharmacol Exp Ther 1974; 191: 377–83
- Bienhold H, Flohr H. Role of commissured connections between vestibular nuclei in compensation following unilateral labyrinthectomy. J Physiol (Lond) 1978; 284: 178
- Reason J F, Brand R. Motion sickness. Academic Press, New York 1975
- Pyykkö I., Schalén L, Jäntti V, Magnusson M. A reduction of vestibulo-visual integration during transdermally administered scopolamine and dimenhydrinate. A presentation of gain control theory in motion sickness. Acta Otolaryngol (Stockh) 1984; 406: 167–73
- Matsuoka I, Domino E F, Morimoto M. Effects of cholinergic agonists and antagonistics on nucleus vestibularis lateralis unit discharge to vestibular stimulation. Acta Otolaryngol (Stockh) 1975; 80: 422–8
- Pyykkö I., Schalén L, Magnusson M, Matsuoka I. Reduction of nystagmus as a predictor of efficacy of motion sickness remedies. Theoretical and applied aspects of eye movement research, A G Gale, F. Johnson. Elsevier Science Publishers B.V./North-Holland, Amsterdam 1984; 421–7
- Pyykkö I., Schalén L, Matsuoka I. Transdermally administered scopolamine vs. dimenhydrinate. II. Effect on different types of nystagmus. Acta Otolaryngol (Stockh) 1985; 99: 597–604
- Collins W E, Schoeder D J, Elam GW. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular acceleration and to optokinetic stimuli. Aviat Space Environ Med 1982; 53: 1182–9
- Brown D R, Wood CD. Vestibular pharmacology. Trends Pharmacol Sci 1980; 1: 150–3
- Baloh RW. The dizzy patient. Symptomatic treatment of vertigo. Postgrad Med 1983; 73: 317–24
- Graybiel A, Knepton J, Shaw J. Prevention of experimental motion sickness by scopolamine absorbed through the skin. Aviat Space Environ Med 1976; 47: 1096–100
- Pyykkö I., Schalén L, Jäntti V. Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness. Acta Otolaryngol (Stockh) 1985; 99: 588–96
- Gejrot T. Intravenous xylocaine in the treatment of Meniere's disease. Acta Otolaryngol (Stockh) 1976; 82: 301–02
- Flohr H, Abeln W, Lüneborg U. Neurotransmitter and neuromodulator systems involved in vestibular compensation. Adaptive mechanisms in gaze control. Facts and theories, A Berthoz, G. Melville Jones. Elsevier Science Publishers, Amsterdam 1985; 269–77
- Abeln W, Bienhold H, Flohr H. Influence of cholinomimetics and cholinolytics on vestibular compensation. Brain Res 1981; 222: 468
- Bienhold H, Flohr H. Role of cholinergic synapses in vestibular compensation. Brain Res 1980; 195: 476–8
- Zee DS. Vertigo. Current therapy in neurologic disease, RT. Johnson. C.V. Mosby Co., Saint Louis 1985; 8–13
- Ishikawa K, Igarashi M. Effect of diazepam on vestibular compensation in squirrel monkeys. Arch Otolaryngol 1984; 240: 49–54
- Schaefer K P, Meyer DL. Aspects of vestibular compensation in guinea pig. Lesion-induced neuronal plasticity in sensorimotor system, H Flohr, E. Precht. Springer, New York 1981; 197–297
- Wennmo C, Bergenius J, Henriksson N G. Transdermal scopolamine and dimenhydrinate in treatment of acute vertigo. The vestibular system. Neuro-physi-ologic and clinical research, M D Graham, JL. Kemik. Raven Press, New York 1987